Su Ming-Wan, Ni Jing-Nian, Cao Tian-Yu, Wang Shuo-Shi, Shi Jing, Tian Jin-Zhou
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Aging Neurosci. 2021 Oct 20;13:755160. doi: 10.3389/fnagi.2021.755160. eCollection 2021.
Previous studies have reported that olfactory identification deficits may be the earliest clinical features of Alzheimer's disease (AD). However, the association between odor identification and hippocampal atrophy remains unclear. This meta-analysis quantified the correlation between odor identification test scores and hippocampal volume in AD. A search of the PUBMED, EMBASE, and WEB OF SCIENCE databases was conducted from January 2003 to June 2020 on studies with reported correlation coefficients between olfactory identification score and hippocampal volume in patients with amnestic AD or mild cognitive impairment (MCI). The quality of the studies was assessed using the Newcastle-Ottawa quality assessment scale (NOS). Pooled values were combined and computed in R studio. Seven of 627 original studies on AD/MCI using an olfactory identification test ( = 902) were included. A positive correlation was found between hippocampal volume and olfactory test scores ( = 0.3392, 95% CI: 0.2335-0.4370). Moderator analysis showed that AD and MCI patients were more profoundly correlated than normal controls (AD: = 0.3959, 95% CI: 0.2605-0.5160; MCI: = 0.3691, 95% CI: 0.1841-0.5288; NC: = 0.1305, 95% CI: -0.0447-0.2980). Age difference and patient type were the main sources of heterogeneity in this analysis. The correlation appears to be more predominant in the cognitive disorder group (including MCI and AD) than in the non-cognitive disorder group. Age is an independent factor that affects the severity of the correlation during disease progression. The mildness of the correlation suggests that olfactory tests may be more accurate when combined with other non-invasive examinations for early detection. https://inplasy.com/, identifier INPLASY202140088.
先前的研究报告称,嗅觉识别缺陷可能是阿尔茨海默病(AD)最早的临床特征。然而,气味识别与海马萎缩之间的关联仍不明确。这项荟萃分析量化了AD患者气味识别测试分数与海马体积之间的相关性。于2003年1月至2020年6月在PUBMED、EMBASE和科学网数据库中检索有关遗忘型AD或轻度认知障碍(MCI)患者嗅觉识别分数与海马体积之间报告相关系数的研究。使用纽卡斯尔-渥太华质量评估量表(NOS)评估研究质量。在R studio中合并并计算合并值。纳入了627项使用嗅觉识别测试的AD/MCI原始研究中的7项(n = 902)。发现海马体积与嗅觉测试分数之间存在正相关(r = 0.3392,95%CI:0.2335 - 0.4370)。亚组分析表明,AD和MCI患者的相关性比正常对照更显著(AD:r = 0.3959,95%CI:0.2605 - 0.5160;MCI:r = 0.3691,95%CI:0.1841 - 0.5288;NC:r = 0.1305,95%CI: - 0.0447 - 0.2980)。年龄差异和患者类型是该分析中异质性的主要来源。这种相关性在认知障碍组(包括MCI和AD)中似乎比非认知障碍组更显著。年龄是疾病进展过程中影响相关性严重程度的一个独立因素。相关性的轻度表明,嗅觉测试与其他非侵入性检查联合用于早期检测时可能更准确。https://inplasy.com/,标识符INPLASY202140088 。